FCR and Bevacizumab in the Treatment of Relapsed Chronic Lymphocytic Leukemia (CLL)
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if the combination of fludarabine,
cyclophosphamide, rituximab, and bevacizumab is effective in treating chronic lymphocytic
leukemia in patients who have already been treated with chemotherapy. The safety of this
treatment will also be studied.